New York, NY -- (SBWIRE) -- 12/12/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: International Stem Cell Corp (OTCMKTS:ISCO), Select Medical Holdings Corporation (NYSE:SEM), Charles Schwab Corp (NYSE:SCHW), Echo Therapeutics Inc (NASDAQ:ECTE)
International Stem Cell Corp (OTCMKTS:ISCO) showed a volume of 3.06 million shares by the end of last trade whereas the average volume of the stock remained 594,167.00 shares. The stock opened the session at $0.19 but then moved to $0.240. At that price, the stock showed a positive performance of 23.08%. International Stem Cell Corporation is a developmental-stage biotechnology company. The Company focused on therapeutic, biomedical and cosmeceutical product. The Company’s wholly owned subsidiary Lifeline Cell Technology, LLC (Lifeline) develops manufactures and commercializes human cells and the reagents needed to culture and study human cells.
Will ISCO Continue To Move Higher? Find Out Here
Select Medical Holdings Corporation (NYSE:SEM) opened the session at $8.96 and closed the session at $10.46. The stock showed a positive performance of 18.06% in previous trading session. Traded with volume of 6.66 million shares in the prior session and the average volume of the stock remained 792,067.00 shares. Select Medical Holdings Corporation is an operator of both specialty hospitals and outpatient rehabilitation clinics in the United States. It also provides medical rehabilitation services on a contract basis at nursing homes, hospitals, assisted living and senior care centers, schools and worksites.
For How Long SEM will fight for Profitability? Read This Trend Analysis report
Charles Schwab Corp (NYSE:SCHW) opened the session at $24.80 and closed the session at $24.86. The stock showed a positive performance of 0.12% in previous trading session. Traded with volume of 10.63 million shares in the prior session and the average volume of the stock remained 6.99 million shares. The beta of the stock remained 1.48. The Charles Schwab Corporation (CSC) is a savings and loan holding company. The Company engages, through its subsidiaries, in securities brokerage, banking, and related financial services. The Company provides financial services to individuals and institutional clients through two segments: Investor Services and Institutional Services.
Why Should Investors Buy SCHW After The Recent Gain? Just Go Here and Find Out
Echo Therapeutics Inc (NASDAQ:ECTE) the stock advanced 14.68% and finished the session at $3.36. Traded with volume of 3.18 million shares in the prior session and the average volume of the stock remained 788,918.00 shares. The beta of the stock remained 0.07. Echo Therapeutics, Inc. (Echo) is a transdermal medical device company. The Company is developing Prelude SkinPrep System (Prelude) as a technology to allow for painless and skin permeation that enable both needle-free drug delivery and analyte extraction. Utilizing this technology, the Company is developing its needle-free Symphony tCGM System (Symphony), as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM), system for use in hospital critical care units and for people with diabetes.
Will ECTE Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)